Abbott Laboratories (BCBA:ABT)
Argentina · Delayed Price · Currency is ARS 49,080
-2,970 (-5.71%)
At close: Oct 9, 2025
Abbott Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Net Income | 13,979 | 13,402 | 5,723 | 6,933 | 7,071 | 4,495 | Upgrade |
Depreciation & Amortization | 3,141 | 3,218 | 3,243 | 3,267 | 3,538 | 3,327 | Upgrade |
Stock-Based Compensation | 659 | 673 | 644 | 685 | 640 | 546 | Upgrade |
Other Adjustments | - | 482 | 126 | 215 | 55 | 425 | Upgrade |
Change in Receivables | -887 | -691 | -356 | -68 | -383 | -924 | Upgrade |
Changes in Inventories | 203 | -58 | -232 | -1,413 | -456 | -493 | Upgrade |
Changes in Accounts Payable | - | 356 | -760 | 420 | 1,288 | 1,766 | Upgrade |
Changes in Income Taxes Payable | - | -8,028 | -585 | -383 | -908 | -614 | Upgrade |
Changes in Other Operating Activities | -72 | -796 | -542 | -75 | -312 | -627 | Upgrade |
Operating Cash Flow | 9,037 | 8,558 | 7,261 | 9,581 | 10,533 | 7,901 | Upgrade |
Operating Cash Flow Growth | 14.39% | 17.86% | -24.21% | -9.04% | 33.31% | 28.77% | Upgrade |
Capital Expenditures | -2,262 | -2,207 | -2,202 | -1,777 | -1,885 | -2,177 | Upgrade |
Purchases of Investments | - | -169 | -159 | -185 | -173 | -83 | Upgrade |
Proceeds from Sale of Investments | -65 | 28 | 43 | 152 | 77 | 10 | Upgrade |
Payments for Business Acquisitions | - | - | -877 | - | -187 | -42 | Upgrade |
Proceeds from Business Divestments | - | 1 | 40 | 48 | 134 | 58 | Upgrade |
Other Investing Activities | 14 | 9 | 22 | 22 | 26 | 19 | Upgrade |
Investing Cash Flow | -2,512 | -2,338 | -3,133 | -1,740 | -2,008 | -2,215 | Upgrade |
Long-Term Debt Issued | 5 | 223 | 2 | 7 | 4 | 1,281 | Upgrade |
Long-Term Debt Repaid | -1,644 | -660 | -2,498 | -753 | -48 | -1,333 | Upgrade |
Net Long-Term Debt Issued (Repaid) | -1,639 | -437 | -2,496 | -746 | -44 | -52 | Upgrade |
Issuance of Common Stock | 439 | 264 | 167 | 167 | 255 | 245 | Upgrade |
Repurchase of Common Stock | -1,352 | -1,295 | -1,227 | -3,795 | -2,299 | -403 | Upgrade |
Net Common Stock Issued (Repurchased) | -913 | -1,031 | -1,060 | -3,628 | -2,044 | -158 | Upgrade |
Common Dividends Paid | -3,973 | -3,836 | -3,556 | -3,309 | -3,202 | -2,560 | Upgrade |
Other Financing Activities | 18 | -100 | 21 | 47 | -204 | -9 | Upgrade |
Financing Cash Flow | -6,589 | -5,404 | -7,091 | -7,636 | -5,494 | -2,779 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 28 | -96 | -23 | -122 | -70 | 71 | Upgrade |
Net Cash Flow | -36 | 720 | -2,986 | 83 | 2,961 | 2,978 | Upgrade |
Beginning Cash & Cash Equivalents | 6,987 | 6,896 | 9,882 | 9,799 | 6,838 | 3,860 | Upgrade |
Ending Cash & Cash Equivalents | 6,951 | 7,616 | 6,896 | 9,882 | 9,799 | 6,838 | Upgrade |
Free Cash Flow | 6,775 | 6,351 | 5,059 | 7,804 | 8,648 | 5,724 | Upgrade |
Free Cash Flow Growth | 6.68% | 25.54% | -35.17% | -9.76% | 51.08% | 27.26% | Upgrade |
FCF Margin | 15.72% | 15.14% | 12.61% | 17.88% | 20.08% | 16.54% | Upgrade |
Free Cash Flow Per Share | 3.88 | 3.63 | 2.89 | 4.42 | 4.83 | 3.20 | Upgrade |
Levered Free Cash Flow | 13,350 | 5,450 | 2,149 | 6,226 | 8,292 | 5,625 | Upgrade |
Unlevered Free Cash Flow | 14,311 | 5,528 | 4,485 | 7,019 | 8,520 | 6,003 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.